The short-term physiological impact of switching reusable silicone hydrogel wearers into a hydrogel daily disposable multifocal

Abstract

Purpose: To evaluate ocular physiological responses to etafilcon A multifocal (etMF) daily disposable (DD) lenses after 4 weeks of wear, when switching from habitual silicone hydrogel (SiHy) daily wear.

Method: A single-arm, open-label, bilateral dispensing study was conducted in 39 habitual spherical SiHy wearers (14 hyperopes; 25 myopes). Clinical visits occurred with habitual SiHy (control) at baseline and after 4 weeks of etMF DD open-eye lens wear at exit. Objective limbal/bulbar hyperemia using the Oculus K5M (0–4) and subjective grading of lid wiper epitheliopathy (LWE) (0–4) were tested for non-inferiority (NI), using a margin of 1 grade. Corneal thickness along a 10 mm cord was measured using the Visante OCT and tested for NI using a 30 μm margin. Corneal staining area was graded (0–100%).

Results: The least-square mean differences (LSMD) and 95% confidence interval (95% CI) between etMF DD and habitual SiHy in central and peripheral corneal thickness (μm) were 3.64 (−2.0, 9.29) and 3.0 (−7.72, 13.72) in hyperopic, and 3.56 (−0.66, 7.78) and 6.40 (−1.62, 14.42) in myopic subjects. The LSMD (95% CI) for bulbar and limbal hyperemia were −0.08 (−0.19, 0.02) and −0.01 (−0.12, 0.09) in hyperopes, and 0.04 (−0.03, 0.12) and 0.04 (−0.04, 0.11) in myopes. The LSMD (95% CI) for LWE were 0.11 (−0.39, 0.60) and 0.30 (−0.07, 0.67) for hyperopes and myopes, respectively.

Conclusions: No clinically significant differences in a variety of physiological responses were found when habitual reusable SiHy daily wear subjects were refitted into hydrogel etMF, when the subjects were followed for 4 weeks.

Keywords:

• corneal swelling
• corneal thickness
• limbal hyperemia
• oxygen transmissibility
• presbyopia
• OCT

Introduction

Soft contact lenses act as a barrier to oxygen transport to the cornea, limiting the availability of atmospheric oxygen for normal corneal metabolism.¹ Corneal swelling occurs as a result of stromal lactic acid accumulation from increased corneal anaerobic metabolic activity,² and it is widely accepted as the main index of corneal oxygen deficiency.^1,3,4 The inverse relationship between soft lens oxygen transmissibility and the amount of induced corneal thickening is well established in the literature.⁵ Maximum corneal swelling occurs in overnight contact lens (CL) wear due to further oxygen deprivation under a closed lid.⁶

Highly oxygen permeable silicone hydrogel (SiHy) soft lenses were commercialized at the end of the last millennium, with the initial intention of reducing the rate of adverse events seen with conventional hydrogel lenses in extended wear.⁷ However, the potential promise of a reduced incidence of microbial keratitis (MK) with SiHy lenses has not been fulfilled and the rates of MK have remained largely unchanged.⁸ Despite the failure of SiHy lenses to alter MK rates during overnight wear, SiHy lenses were rapidly adopted for use on a daily wear basis and now account for over 65% of the new fits in many markets around the world⁹ and have progressively replaced reusable hydrogel lenses as the first choice material for daily wear. This rapid increase in the use of SiHy lenses has been attributed to their perceived superior clinical performance, largely due to their higher oxygen transmissibility (Dk/t; unit = [cm mL O₂]/[mL s mmHg]) producing fewer signs of both acute and chronic hypoxia. These clinical signs include corneal swelling, limbal hyperemia, myopic creep, epithelial microcysts and stromal striae.^10–15 Despite these advantages, a recent review¹⁶ of lens-related corneal infiltrative events (CIEs) pointed to several studies that showed an approximately two times higher relative risk of developing CIEs with reusable SiHy lenses compared to hydrogel lenses.^17–19

Technological advances facilitated by the high Dk/t of SiHy materials present potential opportunities for expanding the use of contact lenses in areas that have exhibited limited uptake in the past, such as astigmatism and presbyopia,²⁰ where the thicker designs resulted in hypoxia. Indeed, many companies now offer both toric and presbyopic designs in SiHy materials and these options continue to increase in popularity.^9,21–23 However, SiHy materials have been associated with reduced in-eye wetting in some patients with poor quality tear films²⁴ and may also deposit tear film lipids to a greater extent than hydrogels.^25–27 Thus, while SiHy materials have benefits from an oxygen transport perspective, the material may not be as clinically acceptable in an older individual with a dry eye or inferior quality tear film,^28,29 and it could be argued that these patients may be more optimally fitted with a hydrogel material. Besides, some patients may have a comfort preference for hydrogel lenses,^30,31 likely due to higher hydrophilicity and/or lower modulus^32–35 of hydrogel materials. It is also worth noting that, in clinical situations, various multifocal (MF) optical designs exist,^36–43 with some of them being unique to certain lens materials. However, not every patient is successful with every MF design.⁴¹ This will inevitably result in patient preference for certain MF designs, some of which may only be available in hydrogel materials.

A new multifocal daily disposable CL (1-Day Acuvue Moist Multifocal)^44,45 is available commercially. This lens varies in design depending upon the distance prescription and age, with a change in each design to acknowledge the change in pupil size that occurs with age and prescription.^46,47 This lens design is currently only available in a hydrogel material (etafilcon A, 58% water content) that is replaced on a daily disposable (DD) basis, and thus concerns may exist regarding its oxygen performance. This is particularly relevant for wearers who may have previously been wearing a SiHy MF but who prefer the visual performance of the hydrogel lens.

The purpose of this pilot study was to investigate the ocular physiological impact of switching existing wearers of SiHy lenses into this new hydrogel DD MF CL (study test lens/etMF), over the course of four weeks.

Materials and methods

This study was performed in compliance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice (GCP). The study received ethics clearance through the Office of Research Ethics (ORE) at the University of Waterloo. Written informed consent was obtained from all subjects prior to enrolment in the study.

Study design and masking

This was a pilot, prospective, single-arm, open-label, 4-week bilateral eye, dispensing study. There was no wash-out period in this study, and the study design was unable to accommodate either randomization or masking. The study design was set up to mimic the process that would most likely occur in a clinical practice, in which a SiHy MF wearer who was exhibiting performance issues with their lenses (either visually or due to deposition/wetting) would be offered an opportunity to be directly refitted into the hydrogel MF DD option.

Subjects and sample size justification

A sample size for this study was not calculated due to the pilot nature of the study and the fact that no published studies to date have switched presbyopic SiHy wearers into a hydrogel lens.

To be eligible, subjects were required to be between the ages of 40 and 70 years old and to be current spherical SiHy lens wearers (not necessarily SiHy MF) with healthy eyes, vertexed spherical equivalent distance correction between +3.50 and −5.50 D, subjective refraction cylinder of ≤0.75 D, reading addition of +0.75 D to +2.50 D, and distance and near best correctable visual acuity of logMAR 0.1 or better in each eye. Forty-four habitual wearers of SiHy lenses were initially enrolled, from which three subjects were ineligible (screen failures who did not meet the study inclusion/exclusion criteria) and two subjects were eligible but withdrew consent before assignment of the study lens. Thirty-nine eligible subjects (14 hyperopes; 25 myopes, mean±Std age of 57.6±7.4 and 52.8±6.3 years, respectively) were dispensed with the test article and all completed the study. Demographics of the study participants are listed in Table 1.

Table 1 Subject demographics

		Hyperopes
	Completed	Total dispensed	Total not dispensed	Total enrolled
Gender n (%)
Female	13 (92.9)	13 (92.9)	1 (100)	14 (93.3)
Male	1 (7.1)	1 (7.1)	0 (0.0)	1 (6.7)
Age
n	14	14	1	15
Mean	57.6	57.6	57.0	57.6
Std	7.43	7.43	-	7.16
Median	58.0	58.0	57.0	58.0
Min	45.0	45.0	57.0	45.0
Max	67.0	67.0	57.0	67.0
		Myopes
	Completed	Total dispensed	Total not dispensed	Total enrolled
Gender n (%)
Female	19 (76.0)	19 (76.0)	2 (100)	21 (77.8)
Male	6 (24.0)	6 (24.0)	0 (0.0)	6 (22.2)
Age
n	25	25	2	27
Mean	52.8	52.8	58.0	53.2
Std	6.33	6.33	8.49	6.46
Median	51.0	51.0	58.0	52.0
Min	43.0	43.0	52.0	43.0
Max	65.0	65.0	64.0	65.0

Abbreviations: Std, standard deviation; Min, minimum; Max, maximum.

Lenses and solutions

Eligible subjects attended the baseline visit while wearing a fresh pair of their habitual SiHy lenses (control). The habitual lenses included various currently marketed SiHy lenses, as previous research did not show an evidence of any differences in physiological performance of SiHy lenses in daily wear based on their Dk/t.⁴⁸ All habitual SiHy lenses were used on a reusable format, with replacement periods being for 1 month or less, with the exception of 1 subject in the hyperopic and 2 subjects in the myopic group, who were wearing DD SiHy lenses (Table 2).

Table 2 Habitual contact lenses

Habitual SiHy contact lenses	Number of hyperopes	Number of myopes	Total # of subjects
Acuvue Oasys for Presbyopia	–	3	3
Acuvue Oasys with Hydraclear Plus	–	4	4
Air Optix Aqua	2	2	4
Air Optix Aqua Multifocal	5	4	9
Air Optix Night and Day Aqua	–	1	1
Biofinity Multifocal	2	4	6
Clariti 1 Day Multifocal	1	1	2
Dailies Total 1	–	1	1
PureVision	1	1	2
PureVision Multifocal	2	2	4
PureVision 2	–	1	1
PureVision 2 for Presbyopia	1	1	2
Total	14	25	39

Following the initial visit, subjects were then switched to the test lens/etMF (1-Day Acuvue Moist Multifocal lenses, Table 3) for DD wear for the next 28±4 days. There were no contact lens care solutions or any other contact lens care products used in this study. The use of rewetting drops was not permitted in this study to avoid any confounding effects on the study outcome variables.

Table 3 Study lens parameters

Name	1-Day Acuvue^® Moist^® Multifocal Brand (Spherical Lenses)
Manufacturer	Johnson & Johnson Vision
Lens material	etafilcon A
Nominal base curve mm (at 22°C)	8.40
Nominal diameter mm (at 22°C)	14.3
Distance powers (D)	+4.00 to −6.00 in 0.25 D steps
Add power	Low, Mid, High
Water content	58%
Nominal center thickness mm (at −3.00 D)	0.084
Oxygen transmissibility (Dk/t)	25.5
Modality	Daily disposable

Procedures

The study included a screening visit, a baseline visit with a fresh pair of habitual SiHy lenses, followed by bilateral dispensing of etMF lenses. Slit-lamp examination of the cornea, including assessments for the presence of any microcysts and/or striae, was conducted at each study visit. Study lenses were worn on a DD basis for the next four weeks, after which subjects returned for a final visit. The 2 clinical study visits occurred after 6 hrs of open-eye lens wear with habitual SiHy (control) at both the baseline (Bl) visit and after the 4 weeks DD wear of the study lenses. Each subject was instructed to wake at least 2 hrs before lens insertion on the morning of both visits to minimize any residual corneal swelling from overnight eye closure.^49,50

Central corneal thickness immediately after lens removal was measured in the right eye using the Visante optical coherence tomographer (OCT; Carl Zeiss Meditec, Jena, Germany) pachymetry map for corneal thickness data along the horizontal meridian, within a range from – 5 mm to +5 mm around the center of the cornea, using a procedure previously reported.⁵¹ These measurements comprised the average data for the central 0–2 mm cornea, and both temporal and nasal 2–5 mm peri-central, 5–7 mm transitional/midperipheral and 7–10 mm peripheral zones along the horizontal meridian. The mean corneal thickness at each corneal zone (except central) was derived from averaging the temporal and nasal OCT measurements for that zone. The Visante OCT calibration was automatically conducted when the instrument was turned on each study day, using the self-verification test tool provided by the manufacturer.

In addition to corneal thickness, the physiological impact of the lenses was also assessed at the two clinical visits by a) objective grading of bulbar and limbal hyperemia; b) subjective grading of corneal staining area and c) grading of the lid wiper epitheliopathy (LWE). Bulbar and limbal hyperemia were graded using the Oculus K5M (Oculus, Wetzlar, Germany) device (0–4 scale, in 0.1 increments).⁵² Corneal staining by sodium fluorescein was assessed based on percentage area (0–100%) by recording the area of staining (graded in 1% increments) for 5 zones of the cornea.⁵³ Observations were made using a Wratten 12 barrier filter.⁵⁴ LWE (sodium fluorescein) was graded after carefully everting the upper lid (0–4 scale, integer steps, where 0= no staining, 1=1% to 25%, 2=26% to 50%, 3=51% to 75% and 4=76% to 100% staining of wiper area).

Data analysis

All data summaries and statistical analyses were performed using the SAS software Version 9.4 (SAS Institute, Cary, NC). All planned analysis for this study was conducted with an overall type I error rate of 5%.

Corneal thickness, limbal and bulbar hyperemia, and LWE were analyzed separately using a linear mixed model. Comparisons between the test lens and habitual lens were carried out using 95% confidence intervals constructed around least‐square means (LSM) differences (follow-up minus baseline values) from the linear mixed model. For corneal thickness, comparisons between the habitual SiHy lenses and the test Multifocal lens were derived for the respective location (Central, Peri-Central, Mid-peripheral, Peripheral) using the corresponding simultaneous confidence intervals (CIs) of least-square means differences (day 28 - baseline), which were calculated with 95% confidence. A test for non-inferiority of the test lens (etMF DD on day 28) relative to the control lens (habitual SiHy at baseline) was carried out by comparing the upper limit confidence interval of the corresponding LSM difference to the 30 µm margin. If the upper limit was below 30 µm, non-inferiority was concluded. If the upper limit was below 30 µm and the lower limit was above −30 µm then clinical equivalence was concluded. Similarly, the non-inferiority analysis was conducted for limbal and bulbar hyperemia and LWE using a 1 grade margin. For conjunctival hyperemia and lid wiper epitheliopathy, the non-inferiority was concluded if the upper confidence limit of LSM difference was less than 1 grade. For mean corneal staining area (%), a test for non-inferiority was planned but could not be conducted due to there being 0% corneal staining in the majority of cases. Therefore, descriptive analyses were used to compare corneal staining between the test and control lenses.

Results

The study test/etMF DD lenses were worn for a mean±std wearing time of 11.4±2.5 hrs/day for 26.7±1.8 days during the study period. After 4 weeks of open-eye wear, no clinically significant differences between any of the study outcome variables for either hyperopes or myopes were found when switching from habitual SiHy CLs at baseline into the etMF DD lenses. In addition, slit-lamp examination of the cornea revealed no microcysts and/or striae in any subjects at any study visits.

The test lenses were equivalent to habitual contact lenses for corneal thickness within 4 µm centrally and 7 µm peripherally, which was well within the pre-stated clinical margin of 30 µm in OCT measurement difference between day 28 and baseline. (Figure 1 and Table 4).

Table 4 Least square (LS) mean difference estimates and 95% confidence intervals (CI) of corneal thickness (µm) along horizontal meridian measured with OCT

Location	Subject group	LS-Mean difference	StdErr	Lower CI	Upper CI	Non-inferiority Met?	Equivalence Met?
Central (0–2 mm)	Hyperopes	3.643	2.3281	−2.000	9.286	Yes	Yes
	Myopes	3.560	1.7422	−0.663	7.783	Yes	Yes
	Overall	3.601	1.4539	0.077	7.126	Yes	Yes
Peri-central (2–5 mm)	Hyperopes	3.571	1.8633	−0.402	7.545	Yes	Yes
	Myopes	3.920	1.3943	0.947	6.893	Yes	Yes
	Overall	3.746	1.1636	1.264	6.227	Yes	Yes
Transitional (5–7 mm)	Hyperopes	4.714	2.4698	−0.744	10.172	Yes	Yes
	Myopes	4.560	1.8482	0.476	8.644	Yes	Yes
	Overall	4.637	1.5424	1.229	8.046	Yes	Yes
Peripheral (7–10 mm)	Hyperopes	3.000	5.0689	−7.722	13.722	Yes	Yes
	Myopes	6.400	3.7933	−1.624	14.424	Yes	Yes
	Overall	4.700	3.1656	−1.996	11.396	Yes	Yes

Notes: Alpha level=0.05. Non-inferiority is established if the upper confidence limit is less than 30 microns. Equivalence is established if the upper and lower confidence limits are between ±30 microns.

Abbreviations: LS-Means, least-square means (Day 28 - baseline); StdErr, standard error; CI, confidence limits.

Figure 1 Open-eye corneal thickness (LS mean±CI) across the cornea (OCT) in hyperopes (top) and myopes (bottom) (overall values are not shown to prevent crowding).

There was no significant difference within ±0.1 grade in objective bulbar and limbal hyperemia (which was well within the pre-stated clinical margin of 1 grade in Oculus K5M measurements of bulbar and limbal conjunctival redness) between the test CL and habitual control lenses (Figure 2 and Table 5). There was also no significant difference within 0.3 grade in LWE between the test and control lenses, which was also well within the pre-stated clinical margin of 1 grade (Table 6).

Table 5 Least square (LS) mean difference estimates and 95% confidence intervals (CI) of objective bulbar and limbal hyperemia by Oculus K5M

Type	Subject group	Alpha level	LS-Mean difference	StdErr	Lower CI	Upper CI	Non-inferiority Met?	Equivalence Met?
Bulbar redness	Hyperopes	0.05	−0.081	0.0533	−0.186	0.024	Yes	Yes
	Myopes	0.05	0.042	0.0384	−0.033	0.118	Yes	Yes
	Overall	0.05	−0.019	0.0328	−0.084	0.046	Yes	Yes
Limbal redness	Hyperopes	0.05	−0.012	0.0533	−0.117	0.093	Yes	Yes
	Myopes	0.05	0.037	0.0384	−0.039	0.112	Yes	Yes
	Overall	0.05	0.012	0.0328	−0.052	0.077	Yes	Yes

Notes: Non-inferiority is established if the upper confidence limit is less than 1 grade. Equivalence is established if the upper and lower confidence limits are between ±1 grade.

Abbreviations: LS-Mean, least-square means (Day 28 - Baseline); StdErr, standard error; CI, confidence limits.

Table 6 Least square (LS) mean difference estimates and 95% confidence intervals (CI) of graded lid wiper epitheliopathy

	Subject group	Alpha level	LS-Mean difference	StdErr	Lower CI	Upper CI	Non-inferiority Met?	Equivalence Met?
LWE	Hyperopes	0.05	0.107	0.2430	−0.385	0.600	Yes	Yes
	Myopes	0.05	0.300	0.1819	−0.068	0.668	Yes	Yes
	Overall	0.05	0.204	0.1518	−0.104	0.511	Yes	Yes

Notes: Non-inferiority is established if the upper confidence limit is less than 1 grade. Equivalence is established if the upper and lower confidence limits are between ±1 grade.

Abbreviations: LS-Mean, least-square means (Day 28 - Baseline); StdErr, standard error; CI, confidence limits.

Figure 2 Open-eye objective (Oculus K5M) bulbar (top) and limbal (bottom) hyperemia (LS mean±CI).

There was no corneal staining in 59% of the eyes at baseline or the final visit. Similarly, 36% of the eyes at baseline and 41% of the eyes at the final visit had a graded mean staining of ≤8% of the total corneal area (Figure 3, bottom). The maximum grades of mean corneal staining area were 17% of the entire corneal area in hyperopes and 5% in myopes at baseline, and ≤8% in both subject groups at exit (Figure 3, top and middle).

Figure 3 Frequency (%) of graded mean corneal staining area (%).

Discussion

The major clinical benefits of daily disposable lenses are their convenience and avoidance of solutions and contact lens cases.^55,56 While most of the current DD options (especially in MF designs) are available in hydrogel materials, the majority of reusable contact lenses (including MF lenses) fitted to patients are silicone hydrogels.⁹ This study sought to determine if there were any physiological concerns over a 4-week period if existing wearers of SiHy lenses were switched into a hydrogel MF product.

Ocular physiological response to the study treatment was determined by evaluating corneal thickness, limbal and bulbar hyperemia, LWE and corneal staining. To avoid an averaging effect of the possible different ocular physiological responses in myopic and hyperopic lens wear (due to differences in lens thickness), the study outcome variables were simultaneously analyzed in each subject group.

Corneal swelling/thickening is one of the main indices of corneal physiological change from deficient oxygen metabolism.^57,58 Previous studies for open-eye contact lens wear showed 2–4.8% average central corneal swelling (~11–26 µm central thickening) and a maximum average peripheral swelling of 3.3% (~22 µm) with hydrogel lenses of low oxygen transmissibility.^59–61 A recent study from our group⁵¹ showed central swelling of 0.2% (or ~1.1 µm) and peripheral swelling of 1% (or ~6.7 µm) with open-eye wear of 1-Day Acuvue Moist DD (also manufactured from etafilcon A) hydrogel lenses. In this current study, similarly, we were unable to measure any clinically significant amounts of corneal swelling after 4 weeks of DD wear of the study etMF lens compared to habitual SiHy CL wear at baseline. This was true for the change in both central thickness (3.6 µm of average thickening in either hyperopic or myopic group) and peripheral corneal thickness (3.0 and 6.4 µm of average peripheral thickening in hyperopes and myopes, respectively) (Figure 1). This finding is not unexpected, because manufacturer’s published central Dk/t of 25.5 units for the etafilcon A MF/test lens meets the suggested minimum criterion of 20–24 Dk/t units for daily wear in the central corneal region from the literature.^5,61,62

The lower differential peripheral corneal thickness (Day 28 - baseline) in the hyperopic group (3.0 µm) compared to the myopic group (6.4 µm) in the current study (Table 4) can be explained by greater peripheral oxygen performance of plus powered lenses from their expected thinner peripheral thickness profile. However, the 3.4 µm average difference between peripheral corneal thickening in the myopic and hyperopic groups on day 28 is clinically insignificant, as we did not find any associated statistically or clinically significant difference in limbal hyperemia between the two groups. Limbal hyperemia is regarded as a sign of peripheral corneal oxygen deficiency with open-eye contact lens wear,⁶³ as limbal hyperemia can be eliminated by using highly oxygen transmissible SiHy lenses.^14,63,64 The results of our current study showed that the change in bulbar and limbal hyperemia in either the hyperopic or myopic study group was <±0.1 grade (on a 0–4 scale) by Oculus K5M (Table 5). This small amount of objectively measured change in ocular hyperemia after 4 weeks of switching to study hydrogel DD lenses was not only statistically insignificant but also clinically irrelevant, as the differential hyperemia was far below the suggested criterion of ≥0.40 grade (on a 0–4 hyperemia scale) for clinical significance.⁶⁵ The hyperemia results of this study are in line with findings from our recent DD study⁵¹ that showed a maximum increase in average subjective graded limbal or bulbar hyperemia of ≤0.10 grade (on a 0–4 scale) after 8 hrs of etafilcon A DD wear compared to no lens wear, which was also considered clinically insignificant.

We were also unable to find any clinically significant differences in the subjective grading of LWE score (Table 6) or corneal staining area (%) (Figure 3) after 28 days of switching to etMF DD wear in the current study. Descriptive analysis of the mean corneal staining area showed that after approximately 1 month of the test lens being worn on a DD basis there were no overall clinically significant differences in corneal staining area compared with the habitual SiHy lens at baseline (Figure 3, bottom). The same was also true in either subject group (hyperopia/myopia), although the maximum graded mean corneal staining in the hyperopic group on day 28 was 9% less than with the habitual SiHy lenses at the baseline (Figure 3, top).

Previous reports showed a high prevalence of clinical signs such as corneal staining, conjunctival hyperemia, tear film instability and symptoms of dryness, irritation, and reduced comfort and comfortable wearing time with reusable soft lens wear, and that switching to a DD modality may reduce the rate of some of these clinical problems.^66,67 This study switched patients from a reusable SiHy lens (with the exception of 3 subjects) into a DD hydrogel lens, thus avoiding potential issues associated with the uptake and release of solution-based preservatives^68,69 and subsequent solution-induced corneal staining.^70,71 Avoidance of solutions may have contributed to any reductions in staining or hyperemia reported.

Switching to a DD modality may be beneficial to patients who seek convenience, want occasional lens wear or are at risk of developing complications due to non-compliance with regular lens replacement or their care system. In this study, switching from habitual reusable SiHy lens wear to a hydrogel MF DD resulted in minimal corneal physiological impact in either myopes or hyperopes, as measured by clinically insignificant differences in corneal thickness^51,61 and limbal and bulbar hyperemia^65,72 after 4 weeks of open-eye wear. The minimal impact of the study lenses on corneal physiology is further supported by the presence of clinically insignificant levels of LWE and corneal staining.

The purpose of this study was not to advocate switching current SiHy MF wearers to hydrogel MFs of lower oxygen performance. The goal of this study was to understand the potential physiological consequences of refitting a patient who, for any reason, would be more suited to wearing a DD hydrogel MF lens, whether that be due to comfort or visual reasons. This is a realistic clinical possibility, as clinicians fitting MF lenses are aware. Analysis of the objective physiological outcomes in our study showed that switching from a reusable SiHy lens to the DD hydrogel MF lenses did not adversely impact ocular physiology in daily wear, despite their lower oxygen transmissibility, over a 4-week period. In light of the absence of any other reports in the literature on the ocular physiological outcomes of refitting current SiHy wearers with hydrogels, the novel findings may help to make the relevant clinical decisions on available different lens options more informed.

In conclusion, no clinically significant differences in a variety of physiological responses were found when habitual reusable SiHy daily wear subjects were refitted into hydrogel etMF, when the subjects were followed for 4 weeks. This study had some limitations, the major one being that it was not randomized and could not be masked. However, we used objective measures of corneal thickness and ocular redness to measure the main physiological outcome variables of this study. This was also a short-term study which was limited to approximately 1 month. A recent retrospective study in a total of 200 subjects (in parallel groups)⁷³ comparing DD hydrogel and DD SiHy single vision CLs for a 3-month period found similar conclusions to our study. Further long-term studies are required to verify whether the clinical similarities in physiological responses between open-eye wear of DD hydrogel MF and SiHy lenses can hold true for a longer period.

Disclosure

Thomas Karkkainen and Jing Xu are employees of Johnson & Johnson Vision. Thomas Karkkainen also has patents 8,992,012, 8,393,73 and 7,753,521 licensed to Johnson & Johnson Vision. Lyndon Jones has received personal fees from Alcon, CooperVision, Johnson & Johnson Vision, Menicon, Novartis and Ophtecs outside the submitted work. The authors report no other conflicts of interest in this work.

Acknowledgments

This study was supported by Johnson & Johnson Vision. Over the past year, CORE has received research grants from Alcon, Allergan, CooperVision, GLChemtech, Johnson & Johnson Vision, Menicon, Novartis, PS Therapy, Shire and Sightglass outside the submitted work. This work was presented in part as a poster at the American Academy of Optometry annual meeting, November 2016 in Anaheim, CA, USA.